ITK/syk translocation in angioimmunoblastic T-cell lymphoma

American Journal of Surgical Pathology

Volumn 37, Issue 9, 2013, Pages 1456-1457

  Attygalle, Ayoma D ^a   Feldman, Andrew L ^b   Dogan, Ahmet ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMT PROTEIN TYROSINE KINASE; EMT PROTEIN-TYROSINE KINASE; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; TUMOR MARKER;

BIOPSY; CASE REPORT; ENZYMOLOGY; FATALITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOHISTOCHEMISTRY; LETTER; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PROGNOSIS; T CELL LYMPHOMA;

BIOPSY; FATAL OUTCOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, T-CELL; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PROTEIN-TYROSINE KINASES; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84884508208     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182991415     Document Type: Letter

References (15)

1. Dogan A, Gaulard P, Jaffe ES, et al. Angioimmunoblastic T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. World Health Organization Classification of Tumours of Haemopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008:309-311.
2. Mourad N, Mounier N, Briere J, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2008;111:4463-4470.
3. Federico M, Rudiger T, Bellei M, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31:240-246.
4. Attygalle A, Al Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627-633.
5. Huang Y, Moreau A, Dupuis J, et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol. 2009;33:682-690.
6. Pileri SA, Ralfkiaer E, Weisenburger DD, et al. Peripheral T-cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, et al, eds. World Health Organization Classification of Tumours of Haemopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008;308.
7. Bacon CM, Paterson JC, Liu H, et al. Peripheral T-cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma. Br J Haematol. 2008;143:439-441.
8. Hu S, Young KH, Konoplev SN, et al. Follicular T-cell lymphoma: a member of an emerging family of follicular helper T-cell derived T-cell lymphomas. Hum Pathol. 2012;43:1789-1798.
9. Streubel B, Vinatzer U, Willheim M. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia. 2006;20:313-318.
10. Attygalle AD, Kyriakou C, Dupuis J. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol. 2007;31:1077-1088.
11. Remstein ED, Dogan A, Einerson RR, et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol. 2006;30:1546-1553.
12. Feldman AL, Sun DX, Law ME, et al. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia. 2008;22:1139-1143.
13. Dogan A, Ngu LS, Ng SH, et al. Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia. 2005;19:873-875.
14. Lemonnier F, Couronne L, Parrens M, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120:1466-1469.
15. Dierks C, Adrian F, Fisch P, et al. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease. Cancer Res. 2010;70: 6193-6204.